1887

Abstract

L-SIGN is a C-type lectin that is expressed on liver sinusoidal endothelial cells. Capture of (HCV) by this receptor results in -infection of hepatoma cells. L-SIGN alleles have been identified that encode between three and nine tandem repeats of a 23 residue stretch in the juxtamembrane oligomerization domain. Here, it was shown that these repeat-region isoforms are expressed at the surface of mammalian cells and variably bind HCV envelope glycoprotein E2 and HCV pseudoparticles. Differences in binding were reflected in -infection efficiency, which was highest for isoform 7 and lowest for isoform 3. These findings provide a molecular mechanism whereby L-SIGN polymorphism could influence the establishment and progression of HCV infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82034-0
2006-09-01
2019-11-13
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/9/2571.html?itemId=/content/journal/jgv/10.1099/vir.0.82034-0&mimeType=html&fmt=ahah

References

  1. Alvarez, C. P., Lasala, F., Carrillo, J., Muñiz, O., Corbí, A. L. & Delgado, R. ( 2002; ). C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol 76, 6841–6844.[CrossRef]
    [Google Scholar]
  2. Baribaud, F., Pöhlmann, S., Sparwasser, T. & 13 other authors ( 2001; ). Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN. J Virol 75, 10281–10289.[CrossRef]
    [Google Scholar]
  3. Bartosch, B., Vitelli, A., Granier, C. & 7 other authors ( 2003; ). Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem 278, 41624–41630.[CrossRef]
    [Google Scholar]
  4. Bashirova, A. A., Geijtenbeek, T. B. H., van Duijnhoven, G. C. F. & 10 other authors ( 2001; ). A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 193, 671–678.[CrossRef]
    [Google Scholar]
  5. Bergman, M. P., Engering, A., Smits, H. H. & 7 other authors ( 2004; ). Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J Exp Med 200, 979–990.[CrossRef]
    [Google Scholar]
  6. Bernhard, O. K., Lai, J., Wilkinson, J., Sheil, M. M. & Cunningham, A. L. ( 2004; ). Proteomic analysis of DC-SIGN on dendritic cells detects tetramers required for ligand binding but no association with CD4. J Biol Chem 279, 51828–51835.[CrossRef]
    [Google Scholar]
  7. Boisvert, J., He, X.-S., Cheung, R., Keeffe, E. B., Wright, T. & Greenberg, H. B. ( 2001; ). Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. J Infect Dis 184, 827–835.[CrossRef]
    [Google Scholar]
  8. Cambi, A., Gijzen, K., de Vries, I. J. M. & 7 other authors ( 2003; ). The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur J Immunol 33, 532–538.[CrossRef]
    [Google Scholar]
  9. Colmenares, M., Puig-Kröger, A., Muñiz, P. O., Corbí, A. L. & Rivas, L. ( 2002; ). Dendritic-cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human dendritic cells, is a receptor for Leishmania amastigotes. J Biol Chem 277, 36766–36769.[CrossRef]
    [Google Scholar]
  10. Cooper, S., Erickson, A. L., Adams, E. J., Kansopon, J., Weiner, A. J., Chien, D. Y., Houghton, M., Parham, P. & Walker, C. M. ( 1999; ). Analysis of a successful immune response against hepatitis C virus. Immunity 10, 439–449.[CrossRef]
    [Google Scholar]
  11. Cormier, E. G., Durso, R. J., Tsamis, F., Boussemart, L., Manix, C., Olson, W. C., Gardner, J. P. & Dragic, T. ( 2004a; ). L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proc Natl Acad Sci U S A 101, 14067–14072.[CrossRef]
    [Google Scholar]
  12. Cormier, E. G., Tsamis, F., Kajumo, F., Durso, R. J., Gardner, J. P. & Dragic, T. ( 2004b; ). CD81 is an entry coreceptor for hepatitis C virus. Proc Natl Acad Sci U S A 101, 7270–7274.[CrossRef]
    [Google Scholar]
  13. Feinberg, H., Guo, Y., Mitchell, D. A., Drickamer, K. & Weis, W. I. ( 2005; ). Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J Biol Chem 280, 1327–1335.[CrossRef]
    [Google Scholar]
  14. Fournier, C., Sureau, C., Coste, J., Ducos, J., Pageaux, G., Larrey, D., Domergue, J. & Maurel, P. ( 1998; ). In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus. J Gen Virol 79, 2367–2374.
    [Google Scholar]
  15. Fry, D. E. & Flint, L. M., Jr ( 1997; ). Hepatitis: an overview of important issues. Bull Am Coll Surg 82, 8–13.
    [Google Scholar]
  16. Gardner, J. P., Durso, R. J., Arrigale, R. R., Donovan, G. P., Maddon, P. J., Dragic, T. & Olson, W. C. ( 2003; ). L-SIGN (CD209L) is a liver-specific capture receptor for hepatitis C virus. Proc Natl Acad Sci U S A 100, 4498–4503.[CrossRef]
    [Google Scholar]
  17. Garry, R. F. & Dash, S. ( 2003; ). Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins. Virology 307, 255–265.[CrossRef]
    [Google Scholar]
  18. Geijtenbeek, T. B., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C., Adema, G. J., van Kooyk, Y. & Figdor, C. G. ( 2000a; ). Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100, 575–585.[CrossRef]
    [Google Scholar]
  19. Geijtenbeek, T. B. H., Kwon, D. S., Torensma, R. & 9 other authors ( 2000b; ). DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100, 587–597.[CrossRef]
    [Google Scholar]
  20. Geijtenbeek, T. B. H., van Vliet, S. J., Koppel, E. A., Sanchez-Hernandez, M., Vandenbroucke-Grauls, C. M. J. E., Appelmelk, B. & van Kooyk, Y. ( 2003; ). Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 197, 7–17.
    [Google Scholar]
  21. Gramberg, T., Zhu, T., Chaipan, C., Marzi, A., Liu, H., Wegele, A., Andrus, T., Hofmann, H. & Pöhlmann, S. ( 2006; ). Impact of polymorphisms in the DC-SIGNR neck domain on the interaction with pathogens. Virology 347, 354–363.[CrossRef]
    [Google Scholar]
  22. Guo, Y., Atkinson, C. E., Taylor, M. E. & Drickamer, K. ( 2006; ). All but the shortest polymorphic forms of the viral receptor DC-SIGNR assemble into stable homo- and heterotetramers. J Biol Chem 281, 16794–16798.[CrossRef]
    [Google Scholar]
  23. Halary, F., Amara, A., Lortat-Jacob, H. & 7 other authors ( 2002; ). Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 17, 653–664.[CrossRef]
    [Google Scholar]
  24. Ikeda, M., Sugiyama, K., Mizutani, T., Tanaka, T., Tanaka, K., Sekihara, H., Shimotohno, K. & Kato, N. ( 1998; ). Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus. Virus Res 56, 157–167.[CrossRef]
    [Google Scholar]
  25. Klimstra, W. B., Nangle, E. M., Smith, M. S., Yurochko, A. D. & Ryman, K. D. ( 2003; ). DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell- and mammalian cell-derived viruses. J Virol 77, 12022–12032.[CrossRef]
    [Google Scholar]
  26. Knolle, P. A. & Gerken, G. ( 2000; ). Local control of the immune response in the liver. Immunol Rev 174, 21–34.[CrossRef]
    [Google Scholar]
  27. Lavillette, D., Tarr, A. W., Voisset, C. & 7 other authors ( 2005; ). Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 41, 265–274.[CrossRef]
    [Google Scholar]
  28. Lechner, F., Wong, D. K. H., Dunbar, P. R. & 7 other authors ( 2000; ). Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191, 1499–1512.[CrossRef]
    [Google Scholar]
  29. Lee, B., Leslie, G., Soilleux, E. & 8 other authors ( 2001; ). cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J Virol 75, 12028–12038.[CrossRef]
    [Google Scholar]
  30. Liu, H. & Zhu, T. ( 2005; ). Determination of DC-SIGN and DC-SIGNR repeat region variations. Methods Mol Biol 304, 471–481.
    [Google Scholar]
  31. Liu, H., Hwangbo, Y., Holte, S. & 8 other authors ( 2004; ). Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1. J Infect Dis 190, 1055–1058.[CrossRef]
    [Google Scholar]
  32. Liu, H., Carrington, M., Wang, C. & 13 other authors ( 2006; ). Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility. J Infect Dis 193, 698–702.[CrossRef]
    [Google Scholar]
  33. Lozach, P.-Y., Lortat-Jacob, H., de Lacroix de Lavalette, A. & 9 other authors ( 2003; ). DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem 278, 20358–20366.[CrossRef]
    [Google Scholar]
  34. Lozach, P.-Y., Amara, A., Bartosch, B., Virelizier, J.-L., Arenzana-Seisdedos, F., Cosset, F.-L. & Altmeyer, R. ( 2004; ). C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. J Biol Chem 279, 32035–32045.[CrossRef]
    [Google Scholar]
  35. Martin, M. P., Lederman, M. M., Hutcheson, H. B. & 9 other authors ( 2004; ). Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection. J Virol 78, 14053–14056.[CrossRef]
    [Google Scholar]
  36. Marzi, A., Gramberg, T., Simmons, G. & 12 other authors ( 2004; ). DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J Virol 78, 12090–12095.[CrossRef]
    [Google Scholar]
  37. McKeating, J. A., Zhang, L. Q., Logvinoff, C. & 8 other authors ( 2004; ). Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. J Virol 78, 8496–8505.[CrossRef]
    [Google Scholar]
  38. Mitchell, D. A., Fadden, A. J. & Drickamer, K. ( 2001; ). A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J Biol Chem 276, 28939–28945.[CrossRef]
    [Google Scholar]
  39. Mummidi, S., Catano, G., Lam, L., Hoefle, A., Telles, V., Begum, K., Jimenez, F., Ahuja, S. S. & Ahuja, S. K. ( 2001; ). Extensive repertoire of membrane-bound and soluble dendritic cell-specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN1) and DC-SIGN2 isoforms. Inter-individual variation in expression of DC-SIGN transcripts. J Biol Chem 276, 33196–33212.[CrossRef]
    [Google Scholar]
  40. Nattermann, J., Ahlenstiel, G., Berg, T. & 7 other authors ( 2006; ). The tandem-repeat polymorphism of the DC-SIGNR gene in HCV infection. J Viral Hepat 13, 42–46.[CrossRef]
    [Google Scholar]
  41. Pileri, P., Uematsu, Y., Campagnoli, S. & 8 other authors ( 1998; ). Binding of hepatitis C virus to CD81. Science 282, 938–941.[CrossRef]
    [Google Scholar]
  42. Pohlmann, S., Baribaud, F., Lee, B., Leslie, G. J., Sanchez, M. D., Hiebenthal-Millow, K., Münch, J., Kirchhoff, F. & Doms, R. W. ( 2001a; ). DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus. J Virol 75, 4664–4672.[CrossRef]
    [Google Scholar]
  43. Pöhlmann, S., Soilleux, E. J., Baribaud, F., Leslie, G. J., Morris, L. S., Trowsdale, J., Lee, B., Coleman, N. & Doms, R. W. ( 2001b; ). DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans. Proc Natl Acad Sci U S A 98, 2670–2675.[CrossRef]
    [Google Scholar]
  44. Pöhlmann, S., Zhang, J., Baribaud, F. & 7 other authors ( 2003; ). Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 77, 4070–4080.[CrossRef]
    [Google Scholar]
  45. Sakuntabhai, A., Turbpaiboon, C., Casademont, I. & 19 other authors ( 2005; ). A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 37, 507–513.[CrossRef]
    [Google Scholar]
  46. Scarselli, E., Ansuini, H., Cerino, R. & 7 other authors ( 2002; ). The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21, 5017–5025.[CrossRef]
    [Google Scholar]
  47. Serrano-Gómez, D., Domínguez-Soto, A., Ancochea, J., Jimenez-Heffernan, J. A., Leal, J. A. & Corbi, A. L. ( 2004; ). Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin mediates binding and internalization of Aspergillus fumigatus conidia by dendritic cells and macrophages. J Immunol 173, 5635–5643.[CrossRef]
    [Google Scholar]
  48. Snyder, G. A., Ford, J., Torabi-Parizi, P., Arthos, J. A., Schuck, P., Colonna, M. & Sun, P. D. ( 2005; ). Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor. J Virol 79, 4589–4598.[CrossRef]
    [Google Scholar]
  49. Soilleux, E. J., Barten, R. & Trowsdale, J. ( 2000; ). DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13. J Immunol 165, 2937–2942.[CrossRef]
    [Google Scholar]
  50. Tassaneetrithep, B., Burgess, T. H., Granelli-Piperno, A. & 10 other authors ( 2003; ). DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 197, 823–829.[CrossRef]
    [Google Scholar]
  51. Yang, Z.-Y., Huang, Y., Ganesh, L., Leung, K., Kong, W.-P., Schwartz, O., Subbarao, K. & Nabel, G. J. ( 2004; ). pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J Virol 78, 5642–5650.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82034-0
Loading
/content/journal/jgv/10.1099/vir.0.82034-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error